Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart (Q46499527)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2005

Language	Label	Description	Also known as
English	Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart	scientific article published in April 2005

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

1 reference

based on heuristic

inferred from title

Nilanjana Maulik

5

object named as

Nilanjana Maulik

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

author name string

Samarjit Das

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Vijay K T Alagappan

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Debasis Bagchi

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Hari S Sharma

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Dipak K Das

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

publication date

1 April 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Vascular Pharmacology

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

42

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

281-289

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

5-6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide signaling in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Role of STAT3 in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide. Peroxyl radical scavenging as an antiapoptotic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Pharmacological preconditioning with resveratrol: role of nitric oxide

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1152/AJPHEART.01012.2001

Identifiers

10.1016/J.VPH.2005.02.013

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905131

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46499527&oldid=2114455878"